# Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)

> **NCT02308228** · EARLY_PHASE1 · COMPLETED · sponsor: **Philip Kern** · enrollment: 109 (actual)

## Conditions studied

- Aging

## Interventions

- **BEHAVIORAL:** Progressive Resistance Training
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02308228
- **Lead sponsor:** Philip Kern
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-14
- **Primary completion:** 2017-12-14
- **Final completion:** 2018-06-28
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308228, "Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02308228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*